Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Argenta pens discovery deal with BioTie
May 2007
SHARING OPTIONS:

HARLOW, U.K.Argenta Discovery Ltd., a contract and respiratory drug development company, has announced that it has entered into a lead optimization collaboration with BioTie Therapies Corp. Under the deal, the two companies will exploit Argenta's expertise in medicinal chemistry, computer-aided drug design (CADD), and early ADME to advance one of BioTie's novel therapeutics programs.
 
"Argenta has a good reputation in contract drug discovery and we anticipate their skills and know-how will help accelerate this important 'first in class' late discovery program into full preclinical development," says Dr. Timo Veromaa, president and CEO of BioTie.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.